...
首页> 外文期刊>Bioactive Materials >Ultrasmall Ga-ICG nanoparticles based gallium ion/photodynamic synergistic therapy to eradicate biofilms and against drug-resistant bacterial liver abscess
【24h】

Ultrasmall Ga-ICG nanoparticles based gallium ion/photodynamic synergistic therapy to eradicate biofilms and against drug-resistant bacterial liver abscess

机译:基于UltrasmAll Ga-ICG纳米粒子的镓离子/光动力学协同疗法以根除生物膜和抗耐药细菌肝脏脓肿

获取原文

摘要

Pyogenic liver abscess and keratitis are aggressive bacterial infections and the treatment has failed to eradicate bacteria in infectious sites completely owing to the currently severe drug resistance to existing antibiotics. Here, we report a simple and efficient one-step development of ultrasmall non-antibiotic nanoparticles (ICG-Ga NPs) containing clinically approved gallium (III) (Ga 3 ) and liver targeting indocyanine green (ICG) molecules to eradicate multi-drug resistant (MDR) bacteria thought the synergetic effect of photodynamic therapy and iron metabolism blocking. The ICG-Ga NPs induced photodynamic effect could destroy the bacterial membrane, further boost the endocytosis of Ga 3 , then replace iron in bacteria cells to disrupt bacterial iron metabolism, and demonstrate the synergetic bacterial killing and biofilm disrupting effects. The ICG-Ga NPs show an excellent therapeutic effect against extended spectrum β-lactamases Escherichia coli (ESBL E. coli ) and significantly improve treatment outcomes in infected liver abscess and keratitis. Meanwhile, the ultrasmall size of ICG-Ga NPs could be cleared rapid via renal clearance route, guaranteeing the biocompatibility. The protective effect and good biocompatibility of ICG-Ga NPs will facilitate clinical treatment of bacteria infected diseases and enable the development of next-generation non-antibiotic antibacterial agents.
机译:脓素肝脏脓肿和角膜炎是腐蚀性的细菌感染,并且治疗未能因现有抗生素目前严重的耐药性而根本地消除感染性部位的细菌。在这里,我们报告了含有临床批准的镓(III)(GA 3)和肝脏靶向吲哚菁绿(ICG)分子的临床批准的镓(III)(ICG)分子以消除多药物抗性(MDR)细菌认为光动力疗法和铁代谢阻断的协同作用。 ICG-GA NPS诱导的光动力学效果可能会破坏细菌膜,进一步提高GA 3的内吞作用,然后替换铁中的铁在细菌细胞中破坏细菌铁代谢,并证明了协同细菌杀死和生物膜破坏效果。 ICG-GA NPS对扩展光谱β-内酰胺酶大肠杆菌(ESBL大肠杆菌)显示出优异的治疗效果,并显着改善受感染的肝脏脓肿和角膜炎的治疗结果。同时,通过肾间隙途径可以快速清除ICG-GA NP的超大尺寸,保证生物相容性。 ICG-GA NPS的保护作用和良好的生物相容性将促进细菌感染疾病的临床治疗,使下一代非抗生素抗菌剂的发展能够发展。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号